AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2024

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 261 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2024. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2024
NameSharesValueWeighting ↓
BOONE CAPITAL MANAGEMENT LLC 495,089$19,803,5605.16%
LAM GROUP, INC. 130,800$5,232,0004.41%
Capital Impact Advisors, LLC 16,425$657,0001.85%
Mesirow Institutional Investment Management, Inc. 353,447$14,137,8801.24%
Ellsworth Advisors, LLC 86,391$3,455,6400.96%
AlphaCentric Advisors LLC 25,000$1,000,0000.74%
HUSSMAN STRATEGIC ADVISORS, INC. 63,000$2,520,0000.69%
Granite Investment Partners, LLC 397,514$15,900,5600.66%
Bridge City Capital, LLC 48,946$1,957,8400.66%
MOODY ALDRICH PARTNERS LLC 55,734$2,229,3600.44%
Redwood Investments, LLC 26,769$1,063,6800.36%
Portolan Capital Management 108,863$4,354,5200.36%
OBERWEIS ASSET MANAGEMENT INC/ 135,055$5,402,2000.33%
SHAKER INVESTMENTS LLC/OH 18,545$741,8000.32%
FULLER & THALER ASSET MANAGEMENT, INC. 1,272,818$50,912,7180.22%
Alan B Lancz & Associates, Inc. 5,400$216,0000.21%
Virtus Investment Advisers, Inc. 6,109$244,3600.21%
Epoch Investment Partners, Inc. 1,078,852$43,154,0800.20%
JUNCTURE WEALTH STRATEGIES, LLC 11,220$448,8000.19%
Virtus Fund Advisers, LLC 1,178$47,1200.19%
External links

This page lists AMPHASTAR PHARMACEUTICALS IN's shareholders in Q2 2024. To view AMPHASTAR PHARMACEUTICALS IN's shareholder history, click here.